TOday’s Movers: Clorox (NYSE:CLX) Stock Rating Maintained by Morgan Stanley; $128 Target Price Indicates -5.40 % Potential

November 14, 2017 - By Adrian Mccoy

 TOday’s Movers: Clorox (NYSE:CLX) Stock Rating Maintained by Morgan Stanley; $128 Target Price Indicates  5.40 % Potential

Investors sentiment decreased to 0.95 in Q2 2017. Its down 0.01, from 0.96 in 2017Q1. It dived, as 38 investors sold Clorox Co shares while 261 reduced holdings. 65 funds opened positions while 219 raised stakes. 88.17 million shares or 0.11% less from 88.27 million shares in 2017Q1 were reported.

Schaller Inv invested in 0.13% or 1,834 shares. Cypress Asset Tx holds 0.21% in Clorox Co (NYSE:CLX) or 7,665 shares. Lombard Odier Asset Mngmt (Europe) holds 0.01% of its portfolio in Clorox Co (NYSE:CLX) for 1,734 shares. Glg Ltd Liability invested in 6,797 shares or 0.06% of the stock. Autus Asset Ltd Liability Company holds 0.16% or 5,949 shares. Caisse De Depot Et Placement Du Quebec reported 0.01% stake. Dnb Asset Mgmt As has 0% invested in Clorox Co (NYSE:CLX) for 15,540 shares. Federated Invsts Pa holds 1,157 shares. Ifc Hldg Inc Fl reported 0.04% of its portfolio in Clorox Co (NYSE:CLX). Bryn Mawr Trust invested 0.29% in Clorox Co (NYSE:CLX). Asset Management One Co Limited reported 243,435 shares. Hamel Associates, New Jersey-based fund reported 2,575 shares. Tarbox Family Office reported 0.02% of its portfolio in Clorox Co (NYSE:CLX). Gamble Jones Invest Counsel owns 19,153 shares. American Beacon Incorporated reported 768 shares.

Clorox (NYSE:CLX) Rating Reaffirmed

In a report revealed to clients on 2 November, The “Equal-Weight” rating of Clorox (NYSE:CLX) shares was maintained at Morgan Stanley, who now has a $128 TP on the stock. Morgan Stanley’s TP indicates a possible downside of -5.40 % from the current stock price of the company.

Investors sentiment decreased to 0.95 in Q2 2017. Its down 0.01, from 0.96 in 2017Q1. It dived, as 38 investors sold Clorox Co shares while 261 reduced holdings. 65 funds opened positions while 219 raised stakes. 88.17 million shares or 0.11% less from 88.27 million shares in 2017Q1 were reported.

Schaller Inv invested in 0.13% or 1,834 shares. Cypress Asset Tx holds 0.21% in Clorox Co (NYSE:CLX) or 7,665 shares. Lombard Odier Asset Mngmt (Europe) holds 0.01% of its portfolio in Clorox Co (NYSE:CLX) for 1,734 shares. Glg Ltd Liability invested in 6,797 shares or 0.06% of the stock. Autus Asset Ltd Liability Company holds 0.16% or 5,949 shares. Caisse De Depot Et Placement Du Quebec reported 0.01% stake. Dnb Asset Mgmt As has 0% invested in Clorox Co (NYSE:CLX) for 15,540 shares. Federated Invsts Pa holds 1,157 shares. Ifc Hldg Inc Fl reported 0.04% of its portfolio in Clorox Co (NYSE:CLX). Bryn Mawr Trust invested 0.29% in Clorox Co (NYSE:CLX). Asset Management One Co Limited reported 243,435 shares. Hamel Associates, New Jersey-based fund reported 2,575 shares. Tarbox Family Office reported 0.02% of its portfolio in Clorox Co (NYSE:CLX). Gamble Jones Invest Counsel owns 19,153 shares. American Beacon Incorporated reported 768 shares.

Clorox Co (NYSE:CLX) Ratings Coverage

Among 15 analysts covering The Clorox Company (NYSE:CLX), 3 have Buy rating, 2 Sell and 10 Hold. Therefore 20% are positive. The Clorox Company has $15000 highest and $92 lowest target. $125.18’s average target is -7.49% below currents $135.31 stock price. The Clorox Company had 41 analyst reports since August 5, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Tuesday, August 1 by RBC Capital Markets. On Thursday, November 3 the stock rating was maintained by RBC Capital Markets with “Sector Perform”. The firm earned “Equal-Weight” rating on Friday, August 4 by Barclays Capital. Jefferies maintained Clorox Co (NYSE:CLX) rating on Monday, June 12. Jefferies has “Hold” rating and $13600 target. The rating was maintained by Morgan Stanley on Thursday, November 2 with “Equal-Weight”. The stock has “Hold” rating by Jefferies on Monday, July 24. The rating was maintained by RBC Capital Markets with “Sector Perform” on Tuesday, November 3. Sterne Agee CRT initiated the shares of CLX in report on Tuesday, July 21 with “Buy” rating. As per Thursday, August 3, the company rating was maintained by BMO Capital Markets. Consumer Edge Research upgraded Clorox Co (NYSE:CLX) on Friday, November 10 to “Outperform” rating.

The stock increased 0.19% or $0.25 during the last trading session, reaching $135.31. About 799,723 shares traded. Clorox Co (NYSE:CLX) has risen 1.68% since November 14, 2016 and is uptrending. It has underperformed by 15.02% the S&P500.

Wall Street await Clorox Co (NYSE:CLX) to release earnings on February, 2. Analysts forecast EPS of $1.22, down exactly $0.03 or 2.40 % from 2014’s $1.25 EPS. The expected CLX’s profit could reach $157.34M giving the stock 27.73 P/E in the case that $1.22 earnings per share is reported. After posting $1.46 EPS for the previous quarter, Clorox Co’s analysts now forecast -16.44 % negative EPS growth.

The Clorox Company is a manufacturer and marketer of consumer and professional products. The company has market cap of $17.45 billion. The Firm sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. It has a 24.85 P/E ratio. The Firm operates through four divisions: Cleaning, Household, Lifestyle and International.

More important recent Clorox Co (NYSE:CLX) news were published by: Prnewswire.com which released: “Daily Technical Summary Reports on Consumer Goods Stocks — La-Z-Boy, Mohawk …” on November 10, 2017, also Nasdaq.com published article titled: “Clorox Co. Announces 7% Increase In Q1 Earnings”, Nasdaq.com published: “CLX Crosses Above Average Analyst Target” on November 08, 2017. More interesting news about Clorox Co (NYSE:CLX) was released by: Valuewalk.com and their article: “ROIC explains 96% of the valuation difference between 30 top Consumer Staples …” with publication date: November 02, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.